Interestingly, SLC25A21 downregulation was correlated with poor survival in KRAS-mutant CRC (log-rank test P = 0.0336), but not in CRC with WT KRAS (log-rank test P = 0.9206, Figure 1G). This evidence concerns the gene KRAS and colorectal carcinoma.